Email Newsletters

Life Sciences

Conquering cancer in Central Mass., one patient at a time

In 1971, President Richard Nixon declared a “war on cancer.” But despite plenty of research on the...

Analysts brush off BSX settlements in product lawsuits

In May, Marlborough-based Boston Scientific Corp. lost a $100 million verdict in a case over its transvaginal...

Little progress evident in search for leader of life sciences board

The Baker administration is keeping a lockdown on information pertaining to its selection of a high-ranking official to continue carrying out the $1 billion, 10-year life sciences law approved by Gov. Deval Patrick in 2008.

Framingham biopharma preps for preeclampsia market in Marlborough expansion

Framingham biopharmaceutical firm LFB USA has pinned plans to build a new 65,000-square-foot manufacturing and laboratory facility in Marlborough in part on the expectation that its drug, ATryn, will soon receive FDA approval for the treatment of preeclampsia.
ADVERTISEMENT

WPI joins biopharma trade group

Worcester Polytechnic Institute has joined a biomanufacturing industry trade group to help develop technology education and training curricula, the school announced last week.

Biopharma firm plans $37M Marlborough expansion

A Framingham-based biopharmaceutical company wants to expand its operations in Marlborough, with plans to add 50 jobs within the next decade, according to documents provided to the Worcester Business Journal.

James McGorry tapped to lead HART of Holliston

James McGorry will be the next CEO of Holliston-based Harvard Apparatus Regenerative Technology (HART), the company announced today.

Ocata Therapeutics CEO rings NASDAQ opening bell

Paul K. Wotton, president and CEO of Ocata Therapeutics, rang the opening bell at the NASDAQ Marketside in New York City Wednesday morning. "We are pleased to have been invited to open the NASDAQ and as a leader in regenerative ophthalmology are delighted to be part of this leading stock exchange," Paul K. Wotton, president and CEO of Ocata Therapeutics, said in a statement released before the ceremony.
ADVERTISEMENT

U.S. House votes to repeal medical device tax

Legislation repealing the 2.3-percent federal tax on medical devices cleared the U.S. House Thursday on a vote of 280-140, and an industry leader in Massachusetts predicted the proposal would pass the Senate if it emerges for a vote but face a veto from President Obama.

Holliston’s Veristat opens Calif. office

Clinical research company Veristat of Holliston has opened a new office in the Bay Area that will house the company's West Coast operations, it announced Monday.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA